Use Legit.Health AI scoring as trial endpoints in psoriasis and AD
Dermatology trials depend on severity scores that are subjective and costly to collect. Legit.Health provides CE-marked automated scoring and already partners with dermatology pharma, which could make Nanogrow's early trials cheaper and more credible to licensees.
Evidence from the records
- “Computer vision and deep learning on skin images, CE-marked as a medical device, with automated severity scores”
- “allergic asthma, colorectal cancer, psoriasis and atopic dermatitis”
- “Novartis and Almirall”
- If it works
- Objective trial endpoints and a door to Legit.Health's pharma partners for licensing talks.
- First step
- Ask Legit.Health for its clinical-trial service terms and the scores validated for psoriasis and AD.
